Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIT | P10721 | 9/20 | 0.70 |
| ▸ | TYK2 | P29597 | 1/20 | 0.59 |
| ▸ | NPC1 | O15118 | 2/20 | 0.49 |
| ▸ | RAB9A | P51151 | 2/20 | 0.49 |
| ▸ | MAP3K8 | P41279 | 1/20 | 0.48 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.46 |
| ▸ | STK17B | O94768 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | IKBKB | O14920 | 1/20 | 0.41 |
| ▸ | PRKCI | P41743 | 1/20 | 0.40 |
| ▸ | BRAF | P15056 | 1/20 | 0.40 |
| ▸ | CAMKK2 | Q96RR4 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21140938 | 0.85 | KIT (0.76) | KITTYK2NPC1RAB9AMAP3K8 | |
| SCHEMBL15504610 | 0.83 | KIT (1.00) | KITTYK2NPC1RAB9AMAP3K8 | |
| SCHEMBL15516547 | 0.77 | KIT (0.67) | KITTYK2NPC1RAB9AMAP3K8 | |
| SCHEMBL15504609 | 0.76 | KIT (0.71) | KITTYK2NPC1RAB9AMAP3K8 | |
| SCHEMBL15689741 | 0.75 | KIT (0.66) | KITTYK2NPC1RAB9AMAP3K8 | |
| SCHEMBL29892907 | 0.74 | DHODH (0.47) | KITKMT2A | |
| SCHEMBL15515825 | 0.74 | KIT (0.59) | KITTYK2NPC1RAB9AMAP3K8 | |
| SCHEMBL15703490 | 0.74 | TYK2 (0.65) | KITTYK2NPC1RAB9AMAP3K8 | |
| SCHEMBL15504606 | 0.74 | RAB9A (0.68) | KITTYK2NPC1RAB9AMAP3K8 | |
| SCHEMBL15515559 | 0.72 | KIT (1.00) | KITNPC1RAB9AKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190207127-A1 | ORGANIC METAL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICES EMPLOYING THE SAME | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2019-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190207127-A1 | ORGANIC METAL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICES EMPLOYING THE SAME | APOL1, MSL1, MRPS22 | KIT 2452/4885TYK2 2055/4885NPC1 2211/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.